Neuronetics Stock EBITDA
| STIM Stock | USD 0.96 0.01 1.05% |
Neuronetics fundamentals help investors to digest information that contributes to Neuronetics' financial success or failures. It also enables traders to predict the movement of Neuronetics Stock. The fundamental analysis module provides a way to measure Neuronetics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neuronetics stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -22.8 M | -23.9 M |
Neuronetics | EBITDA |
Neuronetics Company EBITDA Analysis
Neuronetics' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Neuronetics EBITDA | (22.76 M) |
Most of Neuronetics' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neuronetics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Neuronetics EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Neuronetics is extremely important. It helps to project a fair market value of Neuronetics Stock properly, considering its historical fundamentals such as EBITDA. Since Neuronetics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Neuronetics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Neuronetics' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Neuronetics Ebitda
According to the company disclosure, Neuronetics reported earnings before interest,tax, depreciation and amortization of (22.76 Million). This is 102.59% lower than that of the Health Care Equipment & Supplies sector and 106.56% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.58% higher than that of the company.
Neuronetics EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Neuronetics' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Neuronetics could also be used in its relative valuation, which is a method of valuing Neuronetics by comparing valuation metrics of similar companies.Neuronetics is currently under evaluation in ebitda category among its peers.
Neuronetics Institutional Holders
Institutional Holdings refers to the ownership stake in Neuronetics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Neuronetics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Neuronetics' value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 305.6 K | Hightower Advisors, Llc | 2024-06-30 | 158.2 K | Assenagon Asset Management Sa | 2024-09-30 | 126 K | State Street Corp | 2024-06-30 | 102.1 K | Accurate Wealth Management, Llc | 2024-09-30 | 99.2 K | Dorsey & Whitney Trust Co Llc | 2024-06-30 | 95.9 K | Gamco Investors, Inc. Et Al | 2024-09-30 | 80 K | Gsa Capital Partners Llp | 2024-09-30 | 78.6 K | Landscape Capital Management,llc | 2024-09-30 | 69.3 K | Archon Capital Management Llc | 2024-06-30 | 2.5 M | Kent Lake Capital Llc | 2024-06-30 | 1.7 M |
Neuronetics Fundamentals
| Return On Equity | -1.0 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.45) % | ||||
| Operating Margin | (0.52) % | ||||
| Current Valuation | 56.49 M | ||||
| Shares Outstanding | 30.35 M | ||||
| Shares Owned By Insiders | 11.00 % | ||||
| Shares Owned By Institutions | 53.32 % | ||||
| Number Of Shares Shorted | 969.05 K | ||||
| Price To Book | 3.12 X | ||||
| Price To Sales | 0.41 X | ||||
| Revenue | 71.35 M | ||||
| Gross Profit | 49.72 M | ||||
| EBITDA | (22.76 M) | ||||
| Net Income | (30.19 M) | ||||
| Cash And Equivalents | 73.7 M | ||||
| Cash Per Share | 2.71 X | ||||
| Total Debt | 62.47 M | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 4.02 X | ||||
| Book Value Per Share | 1.18 X | ||||
| Cash Flow From Operations | (32.04 M) | ||||
| Short Ratio | 4.05 X | ||||
| Earnings Per Share | (1.22) X | ||||
| Target Price | 2.67 | ||||
| Number Of Employees | 203 | ||||
| Beta | 2.22 | ||||
| Market Capitalization | 29.23 M | ||||
| Total Asset | 115.83 M | ||||
| Retained Earnings | (376.08 M) | ||||
| Working Capital | 73.98 M | ||||
| Net Asset | 115.83 M |
About Neuronetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neuronetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neuronetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neuronetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Neuronetics Piotroski F Score and Neuronetics Altman Z Score analysis. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.22) | Revenue Per Share 2.453 | Quarterly Revenue Growth (0.07) | Return On Assets (0.17) | Return On Equity (1.00) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.